吐尽管遵守指导方针:儿童癌症患者吐的控制不足最佳
Rotem Fishel Ben-Kenan1, Lily K Stafford2, M'hamed Temkit3
1Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Pediatric blood & cancer
|October 17, 2024
概括
在儿童癌症患者中,遵守化疗诱导吐 (CINV) 的临床实践指南 (CPG) 显示了低于最佳的控制率. 需要新的治疗方法来改善吐管理和患者的生活质量.
科学领域:
- 儿科瘤学 儿科瘤学
- 临床药理学 临床药理学
- 癌症支持性护理 癌症支持性护理
背景情况:
- 化疗诱导吐 (CINV) 是影响儿童癌症患者生活质量和治疗耐受性的重要副作用.
- 标准化临床实践指南 (CPG) 存在,以管理恶心和吐.
- 改善CINV控制对于有效的儿科癌症治疗至关重要.
研究的目的:
- 评估遵守CPG在新诊断的儿科癌症患者中完全控制急性CINV的有效性.
- 确定与遵守CINV管理的CPG相关的因素.
主要方法:
- 一个回顾性电子仪表板审查136名儿童癌症患者接受他们的第一个化疗周期.
- 监测化疗方案,抗使用和吐发作.
- 将护理分类为与指导方针不一致的,与指导方针一致的或与指导方针一致的PLUS (额外的抗药).
主要成果:
- 总的来说,48%的患者完全控制了吐.
- 29%的患者接受了与指导方针不一致的护理,37%的患者接受了与指导方针一致的护理,34%的患者接受了与指导方针一致的护理.
- 高龄和更高的化疗 emetogenicity 与指导方针一致的护理相关.
结论:
- 对CPG的高度遵守并没有导致儿科患者对CINV的最佳完全控制.
- 持续需要创新和适应风险的治疗策略来改善CINV管理.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
230
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
230
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
179
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
179
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
151
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
151
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
Prevention of Further Absorption of Poison
791
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
791
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


